Search

everythinglearnresearchcommunity

for

Search:↓

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

Baricitinib for alopecia areata may rarely cause eye issues like keratitis.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

5-Alpha Reductase Inhibitors are effective for male hair loss and some skin conditions, but their effectiveness in women and safety concerns require careful use.

Ashwagandha root extract improves skin and hair health without side effects.

Skin lesions in Carney Complex are caused by a gene change in some skin cells that leads to increased pigmentation and may lead to tumors.

Clascoterone is safe for the heart, even at high doses.

Promising cancer treatments were found, but the manufacturer closed.

CD19-CAR T cell therapy may help regenerate skin in systemic sclerosis.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Polymeric micelle nanocarriers deliver adapalene more effectively to hair follicles than commercial products.

Bexarotene gel shows promise as a new treatment for alopecia areata.

The chemical peel improved the appearance of hand spots safely and effectively.

Baricitinib is effective as a treatment for severe hair loss.

Tripterygium wilfordii multiglycoside effectively reduced prostate enlargement in rats without harmful effects.

Autologous Cellular Micrografts effectively treat hair loss with significant improvements and no dangerous side effects.

MendelVar is a tool that helps identify important genes by combining GWAS data with Mendelian disease information.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

Warfarin is effective but risky, requiring careful monitoring to prevent bleeding.

JAK inhibitors show promise in treating difficult skin diseases.

Sonidegib and vismodegib have different side effects and reporting patterns.

Patients with early-onset androgenetic alopecia have a higher risk of metabolic syndrome and carotid arteriosclerosis, suggesting the need for early cardiovascular screening and prevention.

RADA16-I can effectively deliver and release mangiferin, improving its solubility and bioavailability.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.

OR-101 shows promise for treating alopecia areata by improving hair growth.